Madrigal Pharmaceuticals
MDGL
MDGL
208 hedge funds and large institutions have $3.43B invested in Madrigal Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
6% less funds holding
Funds holding: 222 → 208 (-14)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
26% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 46
Holders
208
Holding in Top 10
9
Calls
$440M
Puts
$260M
Top Buyers
| 1 | +$256M | |
| 2 | +$80.9M | |
| 3 | +$80.3M | |
| 4 |
O
OrbiMed
New York
|
+$74.3M |
| 5 |
RI
RTW Investments
New York
|
+$51.2M |
Top Sellers
| 1 | -$80.3M | |
| 2 | -$37.1M | |
| 3 | -$35M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$34.4M |
| 5 |
AC
Armistice Capital
New York
|
-$32.3M |